Follow

"The therapy, called Hemgenix, gained US approval from the Food and Drug Administration on November 22 to treat patients with severe B. Shortly after its approval, CSL Behring, the pharmaceutical company commercializing the drug, announced its price: $3.5 million for a one-time dose. It’s now the most expensive drug in the world."

wired.com/story/the-era-of-one

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.